Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by pinetree2on Nov 23, 2011 10:59am

418 Views

Post# 19261314

Drilling Efforts

Okay -Who exactly is this Saxon drilling company drilling the Mani-1 Well.Is this as often occurs in Columbia, old drilling equipment being used.Often they take who ever is available to drill because of availability.Seems like the new management is at least trying a bit more than previous efforts???I hope in the future top drillers are picked (IF THIS IS THE CASE).Columbian oil companies might have there day but this does get discouraging to say the least.Sorry if I'm venting its just my two worst stocks are ---you guessed it Columbian oil juniours,really played them poorly oh well GLTA - PT2

Bullboard Posts

Rich TV Live’s Stocks to Watch this week (Nov. 15, 2024)